Educational framework

How to evaluate a peptide vendor

Search traffic often lands on “where to buy” intent. This page explains how to evaluate sourcing quality yourself. Pepteligence does not name, rank, or endorse suppliers.

Why this matters

Unlike FDA-approved medications distributed through regulated pharmacies, many peptides circulate through compounding, research-chemical, or informal channels. Identity, purity, endotoxin burden, and stability can vary enormously between batches and sellers. That makes documentation and consistency more important than brand marketing or on-site testimonials.

The goal is not perfection — it is informed skepticism: know what evidence should exist before you trust a vial's label.

Three sourcing categories

These are simplified buckets. Legal status depends on jurisdiction and intended use; treat this as orientation, not legal advice.

Compounding pharmacies

Legitimate US compounding operates under pharmacy oversight and typically requires a prescription where applicable — for example, some compounded semaglutide formulations. This pathway carries the highest regulatory and quality-assurance expectations relative to informal research suppliers.

Research chemicals

Sold labeled “for research only” and not for human consumption. This sits in a complex legal and enforcement landscape; quality between vendors is inconsistent even when labels look similar. Documentation (COAs, testing methodology) matters more than packaging.

Grey market / international

Informal import paths and unclear chain-of-custody elevate counterfeiting, degradation-in-transit, and documentation gaps. Acknowledged here only because readers encounter it — not as a recommendation.

What to look for in any vendor

Use this as a checklist. Missing items do not automatically mean “unsafe,” but they weaken verifiability.

  • Third-party Certificate of Analysis (COA) tied to the specific batch you receive
  • HPLC purity testing — commonly cited threshold ≥98% when methodology is disclosed
  • Mass spectrometry confirming peptide identity (not only “weight check”)
  • Bacterial endotoxin / LAL testing where injectable-grade claims are made
  • Lot tracking and stability-oriented handling (cold chain where appropriate)
  • Transparent sourcing of API synthesis or accredited contract manufacturer where stated
  • Independent reviews on neutral platforms — not only on-site testimonials
  • US-based shipping and reachable customer service for accountability

Red flags

Treat these as disqualifying until explained with verifiable documentation.

  • No COAs, or COAs that do not match your batch / lot identifier
  • “98% pure” marketing without disclosed methodology and lab credentials
  • Pricing far below prevailing market — adulteration and dilution are recurrent issues in grey markets
  • No verifiable physical business address or accountable entity
  • Reviews hosted exclusively on the vendor’s own domain
  • Marketing that asserts medical efficacy or “miracle” outcomes